ATE221057T1 - Quinoneverbindung, seine herstellung und anwendung. - Google Patents

Quinoneverbindung, seine herstellung und anwendung.

Info

Publication number
ATE221057T1
ATE221057T1 AT96927194T AT96927194T ATE221057T1 AT E221057 T1 ATE221057 T1 AT E221057T1 AT 96927194 T AT96927194 T AT 96927194T AT 96927194 T AT96927194 T AT 96927194T AT E221057 T1 ATE221057 T1 AT E221057T1
Authority
AT
Austria
Prior art keywords
optionally substituted
pct
group
sec
substituted hydrocarbon
Prior art date
Application number
AT96927194T
Other languages
English (en)
Inventor
Shigenori Ohkawa
Yasuo Nagai
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ATE221057T1 publication Critical patent/ATE221057T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
    • C07D295/112—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C07D295/116—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings with the doubly bound oxygen or sulfur atoms directly attached to a carbocyclic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT96927194T 1995-08-21 1996-08-19 Quinoneverbindung, seine herstellung und anwendung. ATE221057T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP21162995 1995-08-21
PCT/JP1996/002313 WO1997007109A1 (en) 1995-08-21 1996-08-19 Quinone compound, its production and use

Publications (1)

Publication Number Publication Date
ATE221057T1 true ATE221057T1 (de) 2002-08-15

Family

ID=16608945

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96927194T ATE221057T1 (de) 1995-08-21 1996-08-19 Quinoneverbindung, seine herstellung und anwendung.

Country Status (7)

Country Link
US (1) US6011046A (de)
EP (1) EP0846109B1 (de)
AT (1) ATE221057T1 (de)
AU (1) AU6709896A (de)
CA (1) CA2227985A1 (de)
DE (1) DE69622569T2 (de)
WO (1) WO1997007109A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050261347A1 (en) * 2003-10-24 2005-11-24 Wyeth Dihydrobenzofuranyl alkanamine derivatives and methods for using same
US7435837B2 (en) * 2003-10-24 2008-10-14 Wyeth Dihydrobenzofuranyl alkanamine derivatives and methods for using same
EP1879875A1 (de) * 2005-04-22 2008-01-23 Wyeth Kristallformen von {[(2r)-7-(2,6-dichlorophenyl)-5-fluoro-2,3-dihydro-1-benzofuran-2-yl]methyl}amin-hydrochlorid
EA035619B1 (ru) 2005-06-01 2020-07-16 ПиТиСи ТЕРАПЬЮТИКС, ИНК. Композиции для использования в способе лечения митохондриальных нарушений
JP2009508867A (ja) * 2005-09-15 2009-03-05 エジソン ファーマシューティカルズ, インコーポレイテッド ミトコンドリア病および関連した様態の治療ならびにエネルギーバイオマーカーの調節のための酸化還元活性治療剤のテイル改変体
EP1986636B1 (de) 2006-02-22 2013-04-24 Edison Pharmaceuticals, Inc. Phenol- und 1,4-benzochinon-derivate zur verwendung in der behandlung von erkrankungen der mitochondrien
US7618350B2 (en) * 2007-06-04 2009-11-17 Icon Ip, Inc. Elliptical exercise machine with adjustable ramp
PL2220030T3 (pl) 2007-11-06 2016-07-29 Bioelectron Tech Corp Pochodne 4-(p-chinonylo)-2-hydroksybutanamidu do leczenia chorób mitochondrialnych
WO2009111576A2 (en) 2008-03-05 2009-09-11 Edison Pharmaceuticals, Inc. 2-SUBSTITUTED-p-QUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISEASES
EP2344142B1 (de) 2008-09-10 2024-06-26 PTC Therapeutics, Inc. Behandlung von pervasiven entwicklungsstörungen mit redox-aktiven therapeutika
HUE058877T2 (hu) 2014-12-16 2022-09-28 Ptc Therapeutics Inc (R)-2-hidroxi-2-metil-4-(2,4,5-trimetil-3,6-dioxociklohexa-1,4-dienil)butánamid polimorf és amorf alakjai
EP3389646A1 (de) 2015-12-17 2018-10-24 BioElectron Technology Corporation Flouralkyl, flouralkoxy, phenoxy, heteroaryloxy, alkoxy und amin-1,4-benzochinon-derivate zur behandlung von oxidativen stresserkrankungen

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58177934A (ja) * 1982-04-13 1983-10-18 Takeda Chem Ind Ltd ベンゾキノン誘導体
CA1338012C (en) * 1987-04-27 1996-01-30 John Michael Mccall Pharmaceutically active amines
JPH08768B2 (ja) * 1989-08-24 1996-01-10 武田薬品工業株式会社 神経成長因子分泌誘導剤
US5283546A (en) * 1991-05-13 1994-02-01 Motorola, Inc. Vandal-resistant call box
FR2681324B1 (fr) * 1991-09-18 1993-10-29 Adir Cie Nouveaux derives de la trimetazidine, leur procede de preparation et les compositions pharmaceutiques les contenant.
EP0576766A1 (de) * 1992-06-29 1994-01-05 Novo Nordisk A/S Propanolamin-Derivate, ihre Herstellung und Verwendung
NZ290946A (en) * 1994-08-12 1997-12-19 Toyama Chemical Co Ltd Quinolone- or naphthyridone-carboxylic acid derivatives

Also Published As

Publication number Publication date
CA2227985A1 (en) 1997-02-27
EP0846109B1 (de) 2002-07-24
DE69622569D1 (de) 2002-08-29
AU6709896A (en) 1997-03-12
WO1997007109A1 (en) 1997-02-27
US6011046A (en) 2000-01-04
EP0846109A1 (de) 1998-06-10
DE69622569T2 (de) 2003-01-16

Similar Documents

Publication Publication Date Title
FI941022A0 (fi) Spirosykliset piperidiinijohdannaiset
NO994452L (no) Substituerte 4-arylmetylen-2-imino-2,3-dihydrotiazoler og derivater, og deres farmasöytiske anvendelse
DE69622569D1 (de) Quinoneverbindung, seine herstellung und anwendung.
ATE163545T1 (de) Verwendung von adamantan-derivaten zur behandlung von tinnitus
FI932229A0 (fi) Azabicykliska bryggderivat
DE59409312D1 (de) Imidazopyridine und ihre anwendung zur behandlung von magen-darm krankheiten
ES2132415T3 (es) Nuevos derivados de 5-pirrolil-2-piridilmetilsulfinilbencimidazol.
DE69526726D1 (de) Tetrasubstituierte imidazolderivate, verfahren zu ihrer herstellung, ihre anwendung als medikamente und diese enthaltende pharmazeutischen zusammensetzungen
DE69512208D1 (de) Aminosäurederivate und ihre verwendung als phospholipase-a2-inhibitoren
ATE233741T1 (de) Antivirale 2,4-pyrimidindion-derivate und verfahren zu ihrer herstellung
DE69616357D1 (de) Benzocycloalken-verbindungen mit bindungsaffinität an den melatonin-rezeptor, ihre herstellung und verwendung
ATE223379T1 (de) N-aryloxyethylaminderivate zur behandlung der depression
ATE169635T1 (de) Therapeutische verbindungen für die behandlung von krankheiten, die mit einem glutathion-defizit assoziiert sind, herstellungsprozess und diese enthaltene pharmazeutische zusammensetzungen
SE9702716D0 (sv) Substituted phenylazacycloalkanes in the treatment of cognitive disorders
HUT70761A (en) Alkyl derivatives of trazodone having action for central nervous system, pharmaceutical compositions for preparing thereof
FR2700165B1 (fr) Dérivés de pyrrolidine, leur préparation et les médicaments les contenant.
HU9503099D0 (en) New piperazinyl-alkylthio-pyrimidine derivatives, pharmaceutical compositions containing them, and process for producing the active components
FI112482B (fi) 6,7,8,9-tetrahydro-1H-pyrrolo[3,2-h]isokinoliini- ja 1,6,7,8-tetrahydrobentso[2,1-b;3,4-c]-2,3-dioni-3-oksiimijohdannaisia, menetelmä niiden valmistamiseksi ja niiden käyttö
ATE236879T1 (de) 4-aryl-thio-pyridin-2(1h)-onen, diese enthaltende arzneimittel und ihre anwendungen bei der behandlung von mit hiv zusammenhängenden krankheiten
FR2718135B1 (fr) Procédé de préparation d'hydroxy-7 taxanes.
GB2333293B (en) Process for the preparation of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide used as anti cancer compounds
DK0853619T3 (da) Disubstituerede piperidinderivater
ATE195422T1 (de) Verwendung von piperazinderivaten zur behandlung von kognitiven erkrankungen
DE69503635D1 (de) Pyrrolidinderivate zur behandlung von cck und gastrin-abhängigen erkrankungen
FR2729665B1 (fr) Nouveaux derives de glycylanilides, leur preparation et leur application en therapeutique

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties